Login/Sign Up
MRP ₹86.8
(Inclusive of all Taxes)
₹13.0 Cashback (15%)
Provide Delivery Location
About Ergolin 0.125 Tablet
Ergolin 0.125 Tablet is used to prevent and control postpartum haemorrhage. It is used after delivery for the routine management of uterine atony, subinvolution of the uterus, and haemorrhage.
Ergolin 0.125 Tablet contains Methylergometrine, which works by increasing the smooth muscle contractions of the uterus. This helps compress the blood vessels and controls bleeding after delivery.
Take Ergolin 0.125 Tablet exactly as prescribed by the doctor. In some cases, Ergolin 0.125 Tablet may cause high blood pressure associated with seizures and/or headache, nausea, and vomiting. If the side effects persist or worsen, consult your doctor.
Do not take Ergolin 0.125 Tablet if you are pregnant. Consult your doctor if you are breastfeeding. Ergolin 0.125 Tablet is not recommended for children as safety and effectiveness have not been established. Keep your doctor informed about your health condition and medications to rule out any interactions/side effects.
Uses of Ergolin 0.125 Tablet
Ergolin 0.125 Tablet is used in the treatment of Postpartum haemorrhage. The detailed uses of Ergolin 0.125 Tablet are as follows:
Have a query?
Directions for Use
Medicinal Benefits
Ergolin 0.125 Tablet is indicated in the prevention and control of postpartum haemorrhage. It is used following delivery of the placenta for the routine management of uterine atony (soft and weak uterus after childbirth), subinvolution of the uterus, and haemorrhage. Ergolin 0.125 Tablet contains Methylergometrine, a semi-synthetic ergot alkaloid which works by increasing the smooth muscle contractions of the uterus. This helps compress the blood vessels and controls bleeding after delivery.
How Ergolin 0.125 Tablet Works
Storage
What if I have taken an overdose of Ergolin 0.125 Tablet
Drug Warnings
Do not take Ergolin 0.125 Tablet if you are allergic to any of its components, if you have high blood pressure, toxaemia (a complication of pregnancy characterised by high blood pressure), or if you are pregnant. Inform your doctor if you have coronary artery disease, sepsis, vascular disease, or liver or kidney impairment. Consult your doctor if you are breastfeeding. The safety and effectiveness of Ergolin 0.125 Tablet in children have not been established. Let your doctor know if you are taking prescription/non-prescription medicines, including herbal products and supplements.
Drug-Drug Interactions
Login/Sign Up
Drug-Food Interactions
Login/Sign Up
Diet & Lifestyle Advise
Habit Forming
Therapeutic Class
Alcohol
Caution
It is not known if alcohol affects Ergolin 0.125 Tablet . Please consult your doctor.
Pregnancy
Unsafe
Ergolin 0.125 Tablet is not recommended for use during pregnancy.
Breast Feeding
Caution
Ergolin 0.125 Tablet passes into breastmilk. Avoid breastfeeding during treatment with Ergolin 0.125 Tablet and for 12 hours after the last dose. Please consult your doctor if you have any concerns.
Driving
Caution
It is not known if Ergolin 0.125 Tablet affects your ability to drive.
Liver
Caution
Caution should be exercised while using Ergolin 0.125 Tablet in patients with liver impairment. Please consult your doctor if you have liver problems or any concerns regarding this.
Kidney
Caution
Caution should be exercised while using Ergolin 0.125 Tablet in patients with kidney impairment. Please consult your doctor if you have kidney problems or any concerns regarding this.
Children
Unsafe
Ergolin 0.125 Tablet is not recommended for children as safety and effectiveness have not been established.
Heart
Ergolin 0.125 Tablet may not be safe for patients with heart conditions. Please inform your doctor about any heart-related issues before using Ergolin 0.125 Tablet .
Geriatrics
Caution
Ergolin 0.125 Tablet should be used with caution in elderly patients, as they may be more susceptible to side effects. Dose adjustments may be necessary. Always consult a healthcare professional before use.
Ergolin 0.125 Tablet is used to prevent and control postpartum haemorrhage. It is used after delivery for the routine management of uterine atony, subinvolution of the uterus, and haemorrhage.
Ergolin 0.125 Tablet works by increasing the smooth muscle contractions of the uterus. This helps compress the blood vessels and controls bleeding after delivery.
Ergolin 0.125 Tablet is not recommended for use in people with high blood pressure. Consult your doctor if you have hypertension.
Ergolin 0.125 Tablet may cause nausea or vomiting as a side effect. It is not necessary for everyone taking Ergolin 0.125 Tablet to experience this side effect. However, if the condition persists or worsens, consult your doctor.
Ergolin 0.125 Tablet may be indicated in the management of uterine atony. Uterine atony refers to a weak and soft uterus after childbirth.
Yes, Ergolin 0.125 Tablet may cause decreased milk production if taken by lactating mothers after childbirth. It is recommended to avoid breastfeeding while taking Ergolin 0.125 Tablet for at least 12 hours after your last dose. Consult the doctor if you have any concerns.
Ergolin 0.125 Tablet should not be used to stop uterine bleeding after child birth if the patient has high blood pressure as it may worsen hypertension. Consult the doctor if you have any concerns.
No, Ergolin 0.125 Tablet should not be used to stop menstrual bleeding as it is used to manage and prevent excessive bleeding after childbirth (postpartum haemorrhage).
Ergolin 0.125 Tablet should be taken with or without food as advised by the doctor based on your medical condition.
You should not take Ergolin 0.125 Tablet if you are allergic to any of its ingredients. It should not be taken by individuals with high blood pressure (hypertension), or toxaemia (an abnormal condition associated with the presence of toxic substances in the bloodstream) during pregnancy.
No, breastfeeding should be avoided during treatment with Ergolin 0.125 Tablet and for at least 12 hours after the final dose. Consult the doctor if you have any concerns.
Yes, Ergolin 0.125 Tablet may cause an increase in blood pressure as a common side effect. Consult the doctor before taking Ergolin 0.125 Tablet if you have high blood pressure.
Patients with heart disease may have an increased risk of myocardial ischemia and infarction due to methylergonovine-induced vasospasm. Consult the doctor if you have any heart problems.
The side effects of Ergolin 0.125 Tablet include nausea, vomiting, headache, and hypertension (increased blood pressure) associated with seizures. Consult the doctor if any of these symptoms persist or worsen.
Country of origin
Manufacturer/Marketer address
We provide you with authentic, trustworthy and relevant information
Buy best Obstetrics And Gynaecology products by
Sun Pharmaceutical Industries Ltd
Corona Remedies Pvt Ltd
Serum Institute Of India Pvt Ltd
Akumentis Healthcare Ltd
Bharat Serums and Vaccines Ltd
Emcure Pharmaceuticals Ltd
Intas Pharmaceuticals Ltd
Cipla Ltd
Koye Pharmaceuticals Pvt Ltd
Torrent Pharmaceuticals Ltd
Abbott India Ltd
Zydus Healthcare Ltd
Lupin Ltd
Zydus Cadila
Gufic Bioscience Ltd
Jagsonpal Pharmaceuticals Ltd
Neon Laboratories Ltd
Walter Bushnell
Alembic Pharmaceuticals Ltd
Eris Life Sciences Ltd
Aristo Pharmaceuticals Pvt Ltd
Mankind Pharma Pvt Ltd
Lincoln Pharmaceuticals Ltd
Macleods Pharmaceuticals Ltd
Ajanta Pharma Ltd
Mylan Pharmaceuticals Pvt Ltd
Sanzyme Pvt Ltd
West Coast Pharmaceuticals Pvt Ltd
Xeno Pharmaceuticals
La Renon Healthcare Pvt Ltd
Samarth Life Sciences Pvt Ltd
Vivo Lifesciences Pvt Ltd
Ar-Ex Laboratories Pvt Ltd
Pfizer Ltd
Systopic Laboratories Pvt Ltd
Dewcare Concept Pvt Ltd
Micropolis Lifesciences Pvt Ltd
Remember India Medicos Pvt Ltd
Uniza Healthcare Llp
Zealina Life Sciences Llp
Bayer Zydus Pharma Pvt Ltd
Blisson Mediplus Pvt Ltd
Eurozen Healthcare
Glenmark Pharmaceuticals Ltd
Leeford Healthcare Ltd
Organon India Ltd
Vasu Organics Pvt Ltd
Wellesta Healthcare Pvt Ltd
Alkem Laboratories Ltd
Amelia Healthcare Pvt Ltd
Cadila Pharmaceuticals Ltd
Ferring Pharmaceuticals Pvt Ltd
Fourrts India Laboratories Pvt Ltd
Hetero Healthcare Pvt Ltd
Maneesh Pharmaceuticals Ltd
Pharmanova India Drugs Pvt Ltd
TTK Healthcare Ltd
Win Medicare Ltd
Zuventus Healthcare Ltd
Biological E Ltd
Blisson Medica Pvt Ltd
Cadila Healthcare Ltd
Cheminnova Lifesciences
German Remedies Ltd
Gland Pharma Ltd
Goddres Pharmaceuticals Pvt Ltd
Infallible Pharma Pvt Ltd
Martin & Harris Pvt Ltd
Msn Laboratories Pvt Ltd
Nivian Pharma Llp
Oaknet Healthcare Pvt Ltd
Pharmanova Specialties Pvt Ltd
Shield Healthcare
Svizera Healthcare
Akesiss Pharma Pvt Ltd
Alena Lifesciences Llp
Bio Mines
Chem Med Pharmaceuticals
Eskag Pharma Pvt Ltd
Estragen Pharma Pvt Ltd
Hibiscus Pharmaceuticals Pvt Ltd
Indiabulls Pharmaceuticals Pvt Ltd
Infar India Ltd
Integrace Pvt Ltd
Jay Ell Healthcare Pvt Ltd
Liveon Health Care Pvt Ltd
Medgen Drugs And Laboratories Pvt Ltd
Medishri Healthcare Pvt Ltd
Obsurge Biotech Ltd
Ozone Pharmaceuticals Ltd
Saan Labs
Stoicure Pharmaceuticals Pvt Ltd
Syndicate Life Sciences Pvt Ltd
Synokem Pharmaceuticals Ltd
Uni Sankyo Ltd
Wayonext Pharmaceuticals Pvt Ltd
AQUINNOVA PHARMACEUTICALS
Albert David Ltd
Austen Biologicals
Bestel Laboratories Pvt Ltd